Ethyreal Bio has exited stealth with $101 million in funding, joining the queue of companies preparing to challenge Amgen’s Tepezza. Backed by series A and B round investors, including Atlas Venture ...

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...

Johnson & Johnson is buying cancer tech development company Firefly Bio, Inc. Johnson & Johnson said it has entered into a definitive agreement to buy cancer drug developer Firefly Bio Inc. for $1 ...

Johnson & Johnson JNJ1.61%increase; up pointing triangle has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline. J&J on ...

Johnson & Johnson (JNJ) has entered into a definitive agreement to acquire Firefly Bio, a biotechnology company advancing its proprietary Firelink degrader antibody conjugate platform, for $1B in cash ...

June 8 (Reuters) - Johnson & Johnson ⁠said ⁠on Monday ⁠it will acquire biotech Firefly Bio for $1 billion in cash, as ‌it looks to expand ‌its cancer drug pipeline. Firefly's ⁠Firelink ⁠platform uses ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Johnson & Johnson said Monday it will ...

Recognizing the urgent need for climate action, much of the fashion industry has adopted carbon reduction targets. An analysis from Stand.earth found that as of 2025, roughly two-thirds of companies ...

SAN FRANCISCO--(BUSINESS WIRE)--Blank Bio, an applied AI research lab training foundation models for RNA, today announced the closing of a $7.2 million seed financing and a strategic collaboration ...

ADELPHI, Md. – Army researchers at the U.S. Army Combat Capabilities Development Command, known as DEVCOM, Army Research Laboratory invented a breakthrough tool for rapidly identifying novel proteins ...